- Home
- RVP vs CVKD Comparison
RVP vs CVKD Comparison
Compare RVP & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- CVKD
- Stock Information
- Founded
- RVP 1994
- CVKD 2022
- Country
- RVP United States
- CVKD United States
- Employees
- RVP N/A
- CVKD N/A
- Industry
- RVP Medical/Dental Instruments
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- RVP Health Care
- CVKD Health Care
- Exchange
- RVP Nasdaq
- CVKD Nasdaq
- Market Cap
- RVP 18.6M
- CVKD 20.8M
- IPO Year
- RVP 2001
- CVKD 2023
- Fundamental
- Price
- RVP $0.60
- CVKD $12.96
- Analyst Decision
- RVP
- CVKD Strong Buy
- Analyst Count
- RVP 0
- CVKD 2
- Target Price
- RVP N/A
- CVKD $46.00
- AVG Volume (30 Days)
- RVP 60.0K
- CVKD 64.9K
- Earning Date
- RVP 11-14-2024
- CVKD 11-07-2024
- Dividend Yield
- RVP N/A
- CVKD N/A
- EPS Growth
- RVP N/A
- CVKD N/A
- EPS
- RVP N/A
- CVKD N/A
- Revenue
- RVP $38,265,097.00
- CVKD N/A
- Revenue This Year
- RVP N/A
- CVKD N/A
- Revenue Next Year
- RVP N/A
- CVKD N/A
- P/E Ratio
- RVP N/A
- CVKD N/A
- Revenue Growth
- RVP N/A
- CVKD N/A
- 52 Week Low
- RVP $0.56
- CVKD $5.40
- 52 Week High
- RVP $1.34
- CVKD $32.55
- Technical
- Relative Strength Index (RSI)
- RVP 37.28
- CVKD 47.69
- Support Level
- RVP $0.62
- CVKD $10.65
- Resistance Level
- RVP $0.75
- CVKD $12.25
- Average True Range (ATR)
- RVP 0.03
- CVKD 1.50
- MACD
- RVP 0.00
- CVKD -0.12
- Stochastic Oscillator
- RVP 1.33
- CVKD 45.85
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.